GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Bax | increases expression | EXP | | 6480464 | CTD | Oxidopamine results in increased expression of BAX protein | PMID:16480889 PMID:21397656 PMID:28802652 PMID:34302886 | Bax | multiple interactions | EXP | | 6480464 | CTD | 5,10,15,20-tetrakis(4-sulfonatophenyl)porphyrinato iron(III) chloride inhibits the reaction [Oxidopamine results in increased expression of BAX protein]; Resveratrol inhibits the reaction [Oxidopamine results in increased expression of BAX protein]; Tea inhibits the reaction [Oxidopamine results in increased expression of BAX protein] | PMID:16480889 PMID:21397656 PMID:34302886 | Bax | affects localization | ISO | BAX (Homo sapiens) | 6480464 | CTD | Oxidopamine affects the localization of BAX protein | PMID:22821850 | Bax | increases expression | ISO | BAX (Homo sapiens) | 6480464 | CTD | Oxidopamine results in increased expression of BAX mRNA; Oxidopamine results in increased expression of BAX protein | PMID:31176653 PMID:32167238 | Bax | multiple interactions | ISO | BAX (Homo sapiens) | 6480464 | CTD | tricetin inhibits the reaction [Oxidopamine results in increased expression of BAX mRNA]; tricetin inhibits the reaction [Oxidopamine results in increased expression of BAX protein]; Valproic Acid inhibits the reaction [Oxidopamine results in increased expression of BAX protein] | PMID:31176653 PMID:32167238 | |
Go Back to source page | Continue to Ontology report |